Literature DB >> 29361089

Differential Susceptibility to T Cell-Induced Colitis in Mice: Role of the Intestinal Microbiota.

Cynthia Reinoso Webb1, Hendrik den Bakker2, Iurii Koboziev1, Yava Jones-Hall3, Kameswara Rao Kottapalli4, Dmitry Ostanin5, Kathryn L Furr1, Qinghui Mu6, Xin M Luo6, Matthew B Grisham1.   

Abstract

One of the best characterized mouse models of the inflammatory bowel diseases (IBD; Crohn's disease, ulcerative colitis) is the CD4+CD45RBhigh T cell transfer model of chronic colitis. Following our relocation to Texas Tech University Health Sciences Center (TTUHSC), we observed a dramatic reduction in the incidence of moderate-to-severe colitis from a 16-year historical average of 90% at Louisiana State University Health Sciences Center (LSUHSC) to <30% at TTUHSC. We hypothesized that differences in the commensal microbiota at the 2 institutions may account for the differences in susceptibility to T cell-induced colitis. Using bioinformatic analyses of 16S rRNA amplicon sequence data, we quantified and compared the major microbial populations in feces from healthy and colitic mice housed at the 2 institutions. We found that the bacterial composition differed greatly between mice housed at LSUHSC vs TTUHSC. We identified several genera strongly associated with, and signficantly overrepresented in high responding RAG-/- mice housed at LSUHSC. In addition, we found that colonization of healthy TTUHSC RAG-/- mice with feces obtained from healthy or colitic RAG-/- mice housed at LSUHSC transferred susceptibility to T cell-induced colitis such that the recipients developed chronic colitis with incidence and severity similar to mice generated at LSUHSC. Finally, we found that the treatment of mice with preexisting colitis with antibiotics remarkably attenuated disease. Taken together, our data demonstrate that specific microbial communities determine disease susceptibility and that manipulation of the intestinal microbiota alters the induction and/or perpetuation of chronic colitis.
© 2018 Crohn’s & Colitis Foundation of America. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Crohn’s disease; inflammatory bowel diseases; microbiota; mouse models; ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 29361089      PMCID: PMC6176899          DOI: 10.1093/ibd/izx014

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  77 in total

1.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis.

Authors:  Noortje G Rossen; Susana Fuentes; Mirjam J van der Spek; Jan G Tijssen; Jorn H A Hartman; Ann Duflou; Mark Löwenberg; Gijs R van den Brink; Elisabeth M H Mathus-Vliegen; Willem M de Vos; Erwin G Zoetendal; Geert R D'Haens; Cyriel Y Ponsioen
Journal:  Gastroenterology       Date:  2015-03-30       Impact factor: 22.682

2.  Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus.

Authors:  R J Cahill; C J Foltz; J G Fox; C A Dangler; F Powrie; D B Schauer
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis.

Authors:  Wendy S Garrett; Carey A Gallini; Tanya Yatsunenko; Monia Michaud; Andrea DuBois; Mary L Delaney; Shivesh Punit; Maria Karlsson; Lynn Bry; Jonathan N Glickman; Jeffrey I Gordon; Andrew B Onderdonk; Laurie H Glimcher
Journal:  Cell Host Microbe       Date:  2010-09-16       Impact factor: 21.023

Review 4.  Mechanisms of inflammation-driven bacterial dysbiosis in the gut.

Authors:  M Y Zeng; N Inohara; G Nuñez
Journal:  Mucosal Immunol       Date:  2016-08-24       Impact factor: 7.313

5.  Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.

Authors:  R Aranda; B C Sydora; P L McAllister; S W Binder; H Y Yang; S R Targan; M Kronenberg
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

6.  Regulation of chronic colitis in athymic nu/nu (nude) mice.

Authors:  F Stephen Laroux; Hillary H Norris; Jeff Houghton; Kevin P Pavlick; Sulaiman Bharwani; Dana M Merrill; John Fuseler; Robert Chervenak; Matthew B Grisham
Journal:  Int Immunol       Date:  2004-01       Impact factor: 4.823

7.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

Authors:  F Powrie; M W Leach; S Mauze; L B Caddle; R L Coffman
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

8.  Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies.

Authors:  Anna Klindworth; Elmar Pruesse; Timmy Schweer; Jörg Peplies; Christian Quast; Matthias Horn; Frank Oliver Glöckner
Journal:  Nucleic Acids Res       Date:  2012-08-28       Impact factor: 16.971

9.  Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice.

Authors:  Frederic A Carvalho; Omry Koren; Julia K Goodrich; Malin E V Johansson; Ilke Nalbantoglu; Jesse D Aitken; Yueju Su; Benoit Chassaing; William A Walters; Antonio González; Jose C Clemente; Tyler C Cullender; Nicolas Barnich; Arlette Darfeuille-Michaud; Matam Vijay-Kumar; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Cell Host Microbe       Date:  2012-08-02       Impact factor: 21.023

Review 10.  Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design.

Authors:  Debby Laukens; Brigitta M Brinkman; Jeroen Raes; Martine De Vos; Peter Vandenabeele
Journal:  FEMS Microbiol Rev       Date:  2015-08-30       Impact factor: 16.408

View more
  19 in total

Review 1.  Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota-A Narrative Review.

Authors:  Iwona Krela-Kaźmierczak; Oliwia Zakerska-Banaszak; Marzena Skrzypczak-Zielińska; Liliana Łykowska-Szuber; Aleksandra Szymczak-Tomczak; Agnieszka Zawada; Anna Maria Rychter; Alicja Ewa Ratajczak; Kinga Skoracka; Dorota Skrzypczak; Emilia Marcinkowska; Ryszard Słomski; Agnieszka Dobrowolska
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

2.  Lack of peptide YY signaling in mice disturbs gut microbiome composition in response to high-fat diet.

Authors:  Aitak Farzi; Chi Kin Ip; Felicia Reed; Ronaldo Enriquez; Geraldine Zenz; Marija Durdevic; Lei Zhang; Peter Holzer; Herbert Herzog
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.191

3.  Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties.

Authors:  Bruk Getachew; Joseph I Aubee; Richard S Schottenfeld; Antonei B Csoka; Karl M Thompson; Yousef Tizabi
Journal:  BMC Microbiol       Date:  2018-12-22       Impact factor: 3.605

4.  Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice.

Authors:  Peter Allan Dobranowski; Chris Tang; Jean Philippe Sauvé; Susan Christine Menzies; Laura May Sly
Journal:  Gut Microbes       Date:  2019-02-13

5.  Vasoactive Intestinal Peptide Deficiency Is Associated With Altered Gut Microbiota Communities in Male and Female C57BL/6 Mice.

Authors:  Manpreet Bains; Caleb Laney; Annie E Wolfe; Megan Orr; James A Waschek; Aaron C Ericsson; Glenn P Dorsam
Journal:  Front Microbiol       Date:  2019-12-02       Impact factor: 5.640

6.  Gut Commensal-Induced IκBζ Expression in Dendritic Cells Influences the Th17 Response.

Authors:  Lena Michaelis; Marcel Treß; Hanna-Christine Löw; Johanna Klees; Christian Klameth; Anna Lange; Anne Grießhammer; Andrea Schäfer; Sarah Menz; Alex Steimle; Klaus Schulze-Osthoff; Julia-Stefanie Frick
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

7.  Effects of C-Terminal Domain of the Heavy Chain of Tetanus Toxin on Gut Microbiota in a Rat Model of Depression.

Authors:  Bruk Getachew; Yousef Tizabi
Journal:  Clin Pharmacol Transl Med       Date:  2019-10-12

Review 8.  Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics.

Authors:  Chenbo Ding; Wendong Tang; Xiaobo Fan; Guoqiu Wu
Journal:  Onco Targets Ther       Date:  2018-08-13       Impact factor: 4.147

9.  A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.

Authors:  Guadalupe Vidal-Martinez; Brandon Chin; Cynthia Camarillo; Gloria V Herrera; Barbara Yang; Irene Sarosiek; Ruth G Perez
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

10.  Effects of Curcumin in a Mouse Model of Very High Fat Diet-Induced Obesity.

Authors:  Iurii Koboziev; Shane Scoggin; Xiaoxia Gong; Parvin Mirzaei; Masoud Zabet-Moghaddam; Mohammad Yosofvand; Hanna Moussa; Yava Jones-Hall; Naima Moustaid-Moussa
Journal:  Biomolecules       Date:  2020-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.